Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 6,510

(https://www.linkedin.com/in/evelyne-yehudit-bischof/) is an expert in internal medicine and oncology, with a focus on preventative and precision medicine, bio-gerontology, and geronto-oncology.

Dr. Bischof is deeply passionate about next-generation medical technology, and the applications of artificial intelligence for biomedical research and practice.

Dr. Bischof spent a decade practicing medicine and performing translational research in Switzerland, US, and China.

Dr. Bischof is a medical doctor with an MD from Max Planck Institute for Molecular Biology and Genetics, and interned at Columbia University, Harvard MGH, and Beth Israel Medical Deaconess.

Dr. Bischof is the author of over 40 peer-reviewed papers and is a frequent speaker at scientific and medical conferences.

Dr. Bischof serves as Assistant Professor — Shanghai University of Medicine and Health Sciences; Associate Faculty Shanghai Jiao Tong University, and Researcher at University Hospital of Basel.

Continue reading “Dr. Evelyne Bischof, MD — Advancing The Frontiers Of Preventative And Precision Longevity Medicine” | >

Using far more advanced imaging techniques than those of their earlier contemporaries, researchers at the DOE’s Argonne National Laboratory are working to develop a brain connectome — an accurate map that lays out every connection between every neuron and the precise location of the associated dendrites, axons, and synapses that help form the communications or signaling pathways of a brain.

Sept. 24 2021 — As part of the Aurora Early Science Program, Nicola Ferrier of Argonne National Laboratory is leading a project that will use exascale computing power to help advance efforts to develop a brain connectome.

Read more | >

With global corporate-venture-capital-backed (CVC) funding reaching $79 billion across 2,099 deals in the first half of 2,021 according to CB Insights, the chances are high that startups will find great opportunities with this growing investor set.

Entrepreneurs, however, are likely to discover that the investment process can be different for CVCs compared to private venture capital firms. While both types of investment firms tend to make decisions via an investment committee (IC), private VCs (inclusive of VCs with corporate backers that have an independent LPA structure) make up their ICs with firm partners and/or other venture-minded people.

But for CVCs investing off a corporate balance sheet, the IC can include corporate-minded people, such as the CEO or business unit leaders, who generally tend to be detached from the venture mindset and the requirements for operating in the VC world. As such, entrepreneurs will realize that a successful CVC investment decision tends to have different requirements compared to a private VC firm’s decision.

Read more | >

Fixing breaks in genes with speed and perfection can be a matter of life and death for most organisms. Even the simplest changes in a sequence risk catastrophe, especially if the altered code is responsible for a critical function.

Over the past half a century, biologists have studied the mechanisms involved to piece together most of the major steps involved in making faithful repairs in DNA. Yet, one part of the process has remained frustratingly unclear.

By marking key enzymes and DNA with fluorescent tags and watching the repair process unfold in real-time in an Escherichia coli model, researchers from Uppsala University in Sweden have filled in missing details on how bacteria find the templates they rely on to keep genetic repairs error-free.

Read more | >

The automobile industry has recently been inclining towards electrical vehicles and governments are doing everything to support this transition. Tesla has been a pioneer and an example in this field. It has launched smart vehicles and maintained the standard. However, no, the company has a rival, and it might be a threat to Tesla’s models.

Lucid Motors is another automobile company making electric vehicles. It just earned a rating of 520 miles (837 km) from the Environmental Protection Agency for the firm’s model of Air Dream Edition. This makes the Lucid Air the longest-range EV the EPA has ever rated, according to a recent press release.

However, EPA has very specific and low context settings for trials. Hence, the speed and other specifications will perform differently in real road scenarios. This model is the longest-range production EV so far. The company’s CTO and CEO Peter Rawlinson has scored a win as the Air Dream Edition exceeds Tesla’s longest-range vehicle, the Model S Long Range Plus, by a staggering 100 miles (161 km).

Read more | >

HI! I am a news anchor and I have a passion for making videos and I love sharing parts of my experience with you, the viewer!

Your support for my channel means a lot. Thanks for watching and if you have any video ideas, shoot me an email, [email protected].

Check out my website, elianasheriff.com.

Follow me on instagram @elianasheriff.
Tweet me @esherifftv.

WANT TO HELP ME MAKE MORE CONTENT?
Head over here: https://www.patreon.com/user?u=47580275

Read more | >

New #preprint from JAX’s Nadia Rosenthal and researchers at Rocky Mountain Laboratories: “Genetically diverse mouse models of SARS-CoV-2 infection recapitulate clinical variation and cytokine responses in COVID-19”

The preprint, which has yet to be peer reviewed, shows that mice with different genetic backgrounds exhibit highly variable responses to SARS-CoV-2 infection, mirroring the large differences in #COVID19 disease severity seen in humans:

Since the advent of the COVID-19 pandemic, tremendous progress has been made in developing effective vaccines against SARS-CoV-2, the coronavirus that causes COVID-19, and in treating ill patients. Nonetheless, much more needs to be learned about SARS-CoV-2 infectivity and COVID-19 progression to lessen the continuing threat of infection, as the recent emergence and rapid spread of the delta variant has emphasized.

Read more | >